In this study, we interrogated the metabolic landscape of tumor-infiltrating CD8+ T cells and show that loss of metabolic regulator PKM2 serves as a key hub controlling TCF1+ central memory-like progenitor cells to improve responsiveness to PD-1 checkpoint blockade. This evidence concerns the gene CD8A and neoplasm.